Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs
about
Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype.Interplay between the Virus and Host in Rift Valley Fever Pathogenesis.Rift Valley fever phlebovirus NSs protein core domain structure suggests molecular basis for nuclear filaments.Rift Valley fever: current challenges and future prospects
P2860
Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Countermeasure development for ...... of major virulence factor NSs
@ast
Countermeasure development for ...... of major virulence factor NSs
@en
type
label
Countermeasure development for ...... of major virulence factor NSs
@ast
Countermeasure development for ...... of major virulence factor NSs
@en
prefLabel
Countermeasure development for ...... of major virulence factor NSs
@ast
Countermeasure development for ...... of major virulence factor NSs
@en
P2860
P356
P1433
P1476
Countermeasure development for ...... of major virulence factor NSs
@en
P2093
Olga Lihoradova
P2860
P356
10.2217/FVL.13.117
P577
2014-01-01T00:00:00Z